Market Summary Follow

NewLink Genetics Corporation is a A biopharmaceutical company

NLNK - Market Data & News

NLNK - Stock Valuation Report

NewLink Genetics Corporation (NLNK) traded on unusually high volume on Mar. 03, as the stock gained 3.6% to close at $20.44. On the day, NewLink Genetics Corporation saw 870,492 shares trade hands on 6,041 trades. Considering that the stock averages only a daily volume of 324,193 shares a day over the last month, this represents a pretty significant bump in volume over the norm.

Generally speaking, when a stock experiences a sudden spike in trading volume, it may be seen as a bullish signal for investors. An increase in volume means more market awareness for the company, potentially setting up a more meaningful move in stock price. The added volume also provides a level of support and stability for price advances.

The stock has traded between $20.21 and $9.23 over the last 52-weeks, its 50-day SMA is now $12.64, and its 200-day SMA $11.90. NewLink Genetics Corporation has a P/B ratio of 4.3.

NewLink Genetics Corp is a biopharmaceutical company. The Company is focused on discovering, developing and commercializing immunotherapeutic products to improve treatment options for patients with cancer.

Headquartered in Ames, IA, NewLink Genetics Corporation has 210 employees and is currently under the leadership of CEO Charles J. Link.

For a complete fundamental analysis analysis of NewLink Genetics Corporation, check out Equities.coms Stock Valuation Analysis report for NLNK.

Want to invest with the experts? Subscribe to Equities Premium newsletters today! Visit http://www.equitiespremium.com/ to learn more about Guild Investments Market Commentary and Adam Sarhans Find Leading Stocks today.

To get more information on NewLink Genetics Corporation and to follow the companys latest updates, you can visit the companys profile page here: NLNKs Profile. For more news on the financial markets and emerging growth companies, be sure to visit Equities.coms Newsdesk. Also, dont forget to sign-up for our daily email newsletter to ensure you dont miss out on any of our best stories.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

View post:
NewLink Genetics Corporation (NLNK) Moves Higher on Volume Spike for March 03 - Equities.com